Filing Details
- Accession Number:
- 0001181431-11-050253
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2011-09-22 17:44:26
- Reporting Period:
- 2011-09-20
- Filing Date:
- 2011-09-22
- Accepted Time:
- 2011-09-22 17:44:26
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1361103 | Complete Genomics Inc | GNOM | Services-Commercial Physical & Biological Research (8731) | 203226545 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1134041 | A Clifford Reid | 2071 Stierlin Court Mountain View CA 94043 | Chief Executive Officer | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock, $0.001 Par Value | Disposition | 2011-09-20 | 4,500 | $7.30 | 314,700 | No | 4 | D | Indirect | By Living Trust |
| Common Stock, $0.001 Par Value | Acquisiton | 2011-09-20 | 8,000 | $1.50 | 8,000 | No | 4 | M | Direct | |
| Common Stock, $0.001 Par Value | Disposition | 2011-09-20 | 8,000 | $7.30 | 0 | No | 4 | S | Direct | |
| Common Stock, $0.001 Par Value | Disposition | 2011-09-21 | 4,500 | $6.80 | 310,200 | No | 4 | D | Indirect | By Living Trust |
| Common Stock, $0.001 Par Value | Disposition | 2011-09-21 | 8,000 | $1.50 | 8,000 | No | 4 | M | Direct | |
| Common Stock, $0.001 Par Value | Disposition | 2011-09-21 | 8,000 | $6.81 | 0 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | D | Indirect | By Living Trust |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | D | Indirect | By Living Trust |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (right to buy) | Disposition | 2011-09-20 | 8,000 | $0.00 | 58,666 | $1.50 |
| Common Stock | Stock Option (right to buy) | Disposition | 2011-09-21 | 8,000 | $0.00 | 50,666 | $1.50 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 58,666 | 2009-09-12 | 2019-12-27 | No | 4 | M | Direct |
| 50,666 | 2009-09-12 | 2019-12-27 | No | 4 | M | Direct |
Footnotes
- The shares sold were pursuant to a Rule 10b5-1 plan dated June 16, 2011. The transaction was executed in multiple trades in prices ranging from $6.90 to $7.42 inclusive. The price reported in Column 4 above reflects the weighted average sales price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer, or a stockholder of the Issuer, information regarding the number of shares and prices at which the transaction was effected.
- These shares are held by the Clifford A. Reid Living Trust, Dated September 3, 1997, Clifford A. Reid, Trustee.
- The shares sold were pursuant to a Rule 10b5-1 plan dated June 16, 2011. The transaction was executed in multiple trades in prices ranging from $6.80 to $7.44 inclusive. The price reported in Column 4 above reflects the weighted average sales price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer, or a stockholder of the Issuer, information regarding the number of shares and prices at which the transaction was effected.
- The shares sold were pursuant to a Rule 10b5-1 plan dated June 16, 2011. The transaction was executed in multiple trades in prices ranging from $6.655 to $7.06 inclusive. The price reported in Column 4 above reflects the weighted average sales price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer, or a stockholder of the Issuer, information regarding the number of shares and prices at which the transaction was effected.
- The shares sold were pursuant to a Rule 10b5-1 plan dated June 16, 2011. The transaction was executed in multiple trades in prices ranging from $6.67 to $7.10 inclusive. The price reported in Column 4 above reflects the weighted average sales price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer, or a stockholder of the Issuer, information regarding the number of shares and prices at which the transaction was effected.
Billionaire Hedge Funds
